EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repeated intravenous transplantation of human umbilical cord mesenchymal stem cells does not promote tumorigenesis in EGFR-mutated lung cancer mice

Zepeng Zhang, Anhua Xu, Qian Zhou, Fei Wen, Fenghua Chen, Hansen Chen, Hu Wang iD, Liang Chen, Zhenyu Ju, Yuanlong Ge

Stem Cells Translational Medicine · 2025

DOI: 10.1093/stcltm/szae065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2025. Verfasst von Zepeng Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, College of Life Science and Technolog…. Hauptthemen laut MEDLINE: Lung Neoplasms, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Umbilical Cord. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem cells (MSCs) are extensively studied in clinical trials for their potential therapeutic applications in degenerative and inflammatory diseases and disorders. Despite the lack of clinical evidence indicating that MSCs induce carcinogenesis, the immunosuppressive and proangiogenic functions of MSCs are considered as potential risks involving immune escape and tumor occurrence in programming tumor microenvironment. Previously, many groups had studied the tumorigenic safety of MSCs, but most of these studies were modeled in immuno-deficient mice with different types and sources of transplanted tumors, leaving varied and controversial conclusions. In this study, we developed a new xenograft model by repeatedly transplanting human umbilical cord mesenchymal stem cells (UC-MSCs) into transgenic mice via tail vein. These mice, carried a human-derived mutated EGFR with a normal immune system, were used to investigate whether UC-MSCs promote the occurrence of lung adenocarcinoma. The duration, dynamics, and pathological characteristics of the early stages of the disease were analyzed. In general, repeated transplantation of UC-MSCs neither accelerated the occurrence of lung cancer and the progression of bronchial alveolar carcinoma nor promoted a pro-tumor immune microenvironment. These results suggest that repeated transplantation of UC-MSCs does not increase the risk of lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMesenchymal Stem Cell TransplantationMesenchymal Stem CellsUmbilical CordCarcinogenesisAnimalsHumansErbB ReceptorsMiceMice, TransgenicTumor MicroenvironmentMutation

Stichwörter der Autor:innen

EGFRUC-MSCadenocarcinomalung cancerxenograft

Substanzen

ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, People's Republic of China.
  • Department of Geriatrics, Medical Center on Aging of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China.
  • MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology,…
  • GCH Regenerative Medicine Group-Jinan University Joint Research and Development Center, Jinan University, Guangzhou 510632, People's Republic of China.

ORCID-Profile: Hu Wang

Förderung

  • National Natural Science Foundation of China
  • Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University

Zitieren

APA

Zhang, Z., Xu, A., Zhou, Q., Wen, F., Chen, F., Chen, H., Wang, H., Chen, L., Ju, Z., & Ge, Y. (2025). Repeated intravenous transplantation of human umbilical cord mesenchymal stem cells does not promote tumorigenesis in EGFR-mutated lung cancer mice. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae065

Vancouver

Zhang Z, Xu A, Zhou Q, Wen F, Chen F, Chen H, et al. Repeated intravenous transplantation of human umbilical cord mesenchymal stem cells does not promote tumorigenesis in EGFR-mutated lung cancer mice. Stem Cells Translational Medicine. 2025. doi:10.1093/stcltm/szae065

BibTeX
@article{Zhang2025,
  author = {Zhang, Zepeng and Xu, Anhua and Zhou, Qian and Wen, Fei and Chen, Fenghua and Chen, Hansen and Wang, Hu and Chen, Liang and Ju, Zhenyu and Ge, Yuanlong},
  title = {Repeated intravenous transplantation of human umbilical cord mesenchymal stem cells does not promote tumorigenesis in EGFR-mutated lung cancer mice},
  journal = {Stem Cells Translational Medicine},
  year = {2025},
  doi = {10.1093/stcltm/szae065}
}
Kostenlos starten →